Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate hears bill to expand Medicaid coverage for GLP-1 medications for obesity with clinical safeguards
Summary
Sponsor proposed adding GLP-1 drugs to Medicaid coverage for patients meeting BMI and comorbidity criteria to treat obesity as chronic disease; Medicaid officials said many GLP-1 uses are already covered for diabetes and for BMI with comorbidities, and that a revised fiscal note will be needed for any coverage change.
Sen. Sue Prentiss introduced legislation to expand Medicaid coverage for GLP-1 agonist medications used to treat obesity when patients meet specified BMI thresholds and comorbidity criteria. The sponsor framed obesity as a chronic disease and argued that treating it earlier with evidence-based medication could prevent costly downstream conditions such as diabetes complications,…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
